The effects of probiotics and synbiotic supplementation on glucose and insulin metabolism in adults with prediabetes: a double-blind randomized clinical trial

被引:63
作者
Kassaian, Nazila [1 ]
Feizi, Awat [2 ,3 ]
Aminorroaya, Ashraf [1 ]
Jafari, Parvaneh [4 ]
Ebrahimi, Maryam Tajabadi [5 ]
Amini, Masoud [1 ]
机构
[1] Isfahan Univ Med Sci, Isfahan Endocrine & Metab Res Ctr, Sedighe Tahere Res Complex,Khoram St, Esfahan, Iran
[2] Isfahan Univ Med Sci, Isfahan Endocrine & Metab Res Ctr, Esfahan, Iran
[3] Isfahan Univ Med Sci, Dept Biostat & Epidemiol, Esfahan, Iran
[4] IAU, Arak Branch, Microbiol Dept, Sci Fac, Arak, Iran
[5] IAU, Tehran Cent Branch, Microbiol Dept, Sci Fac,Tehran Cent Branch, Tehran, Iran
关键词
Probiotics; Synbiotic; Prediabetes; Clinical trial; GUT MICROBIOTA; HIGH-FAT; RESISTANCE; INFLAMMATION; OBESITY; DIET;
D O I
10.1007/s00592-018-1175-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Probiotics and/or prebiotics could be a promising approach to improve metabolic disorders by favorably modifying the gut microbial composition. Objectives To assess the effects of probiotics and synbiotic on glycemic indices in prediabetic individuals who are at risk of type 2 diabetes and its complications. Methods In a double-blind, randomized, placebo-controlled parallel-group clinical trial, 120 prediabetic adults participated and were randomly allocated to receive either probiotics or synbiotic or placebo supplements for 24 weeks. Anthropometric measurements, food record, physical activity and glycemic biomarkers including glycated hemoglobin (HbA1C), fasting plasma glucose (FPG), fasting insulin levels (FIL), homoeostasis model assessment for insulin resistance (HOMA-IR), quantitative insulin sensitivity check index (QUICKI), and beta-cell function (HOMA-B) were assessed at baseline and repeated at 12 and 24 weeks and compared within and between three groups using repeated measure ANOVA. Results Compared with the placebo, synbiotic supplementation resulted in a higher significant reduction in FPG (- 6.5 +/- 1.6 vs. - 0.82 +/- 1.7 mg/dL, P = 0.01), FIL (- 2.6 +/- 0.9 vs. - 0.8 +/- 0.8 mu IU/mL, P = 0.028), and HOMA-IR (- 0.86 +/- 0.3 vs. - 0.16 +/- 0.25, P =0.007), and a significant elevation in the QUICKI (+ 0.01 +/- 0.003 vs. + 0.003 +/- 0.002, P = 0.006). In addition, significant decreases in HbA1C was seen following the supplementation of probiotics and synbiotic compared with the placebo (- 0.12 +/- 0.06 and - 0.14 +/- 0.05 vs. +0.07 +/- 0.06%, P = 0.005 and 0.008, respectively). HOMA-B was not found to be different between or within the three groups. Conclusion Glycemic improvement by probiotics and particularly synbiotic supplements in prediabetic individuals has been supported by current study. However, further studies are required for optimal recommendations in this important area of patient treatment.
引用
收藏
页码:1019 / 1028
页数:10
相关论文
共 38 条
  • [1] Effect of prebiotic supplementation and calcium intake on body mass index
    Abrams, Steven A.
    Griffin, Ian J.
    Hawthorne, Keli M.
    Ellis, Kenneth J.
    [J]. JOURNAL OF PEDIATRICS, 2007, 151 (03) : 293 - 298
  • [2] MECHANISMS IN ENDOCRINOLOGY Gut microbiota in patients with type 2 diabetes mellitus
    Allin, Kristine H.
    Nielsen, Trine
    Pedersen, Oluf
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 172 (04) : R167 - R177
  • [3] Prediabetes diagnosis and treatment: A review
    Bansal, Nidhi
    [J]. WORLD JOURNAL OF DIABETES, 2015, 6 (02) : 296 - 303
  • [4] Carbohydrates and insulin resistance in clinical nutrition: Recommendations from the ESPEN expert group
    Barazzoni, R.
    Deutz, N. E. P.
    Biolo, G.
    Bischoff, S.
    Boirie, Y.
    Cederholm, T.
    Cuerda, C.
    Delzenne, N.
    Leon Sanz, M.
    Ljungqvist, O.
    Muscaritoli, M.
    Pichard, C.
    Preiser, J. C.
    Sbraccia, R.
    Singer, P.
    Tappy, L.
    Thorens, B.
    Van Gossum, A.
    Vettor, R.
    Calder, P. C.
    [J]. CLINICAL NUTRITION, 2017, 36 (02) : 355 - 363
  • [5] Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
    Cani, P. D.
    Possemiers, S.
    Van de Wiele, T.
    Guiot, Y.
    Everard, A.
    Rottier, O.
    Geurts, L.
    Naslain, D.
    Neyrinck, A.
    Lambert, D. M.
    Muccioli, G. G.
    Delzenne, N. M.
    [J]. GUT, 2009, 58 (08) : 1091 - 1103
  • [6] Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
    Cani, Patrice D.
    Bibiloni, Rodrigo
    Knauf, Claude
    Neyrinck, Audrey M.
    Neyrinck, Audrey M.
    Delzenne, Nathalle M.
    Burcelin, Remy
    [J]. DIABETES, 2008, 57 (06) : 1470 - 1481
  • [7] Metabolic endotoxemia initiates obesity and insulin resistance
    Cani, Patrice D.
    Amar, Jacques
    Iglesias, Miguel Angel
    Poggi, Marjorie
    Knauf, Claude
    Bastelica, Delphine
    Neyrinck, Audrey M.
    Fava, Francesca
    Tuohy, Kieran M.
    Chabo, Chantal
    Waget, Aurelie
    Delmee, Evelyne
    Cousin, Beatrice
    Sulpice, Thierry
    Chamontin, Bernard
    Ferrieres, Jean
    Tanti, Jean-Francois
    Gibson, Glenn R.
    Casteilla, Louis
    Delzenne, Nathalie M.
    Alessi, Marie Christine
    Burcelin, Remy
    [J]. DIABETES, 2007, 56 (07) : 1761 - 1772
  • [8] What are the pharmacotherapy options for treating prediabetes?
    Daniele, Giuseppe
    Abdul-Ghani, Muhammad
    DeFronzo, Ralph A.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (14) : 2003 - 2018
  • [9] Probiotics, Prebiotics, and Synbiotics
    de Vrese, Michael
    Schrezenmeir, J.
    [J]. FOOD BIOTECHNOLOGY, 2008, 111 : 1 - 66
  • [10] Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study
    Eslamparast, Tannaz
    Zamani, Farhad
    Hekmatdoost, Azita
    Sharafkhah, Maryam
    Eghtesad, Sareh
    Malekzadeh, Reza
    Poustchi, Hossein
    [J]. BRITISH JOURNAL OF NUTRITION, 2014, 112 (03) : 438 - 445